Clinical & translational oncology

• 

  Año 2011, Vol. 13, Número 6

  • Oxaliplatin, colorectal cancer and predictive factors

    Albert Abad Esteve

    págs. 353-354

    

  • The importance of the White Book of Radiation Oncology

    Ferrán Guedea Edo, Alfredo Ramos

    págs. 355-356

    

  • microRNAs as novel epigenetic biomarkers for human cancer

    María Cortés Sempere, I. Ibáñez de Cáceres

    • Resumen

    págs. 357-362

    

  • Metformin:: a new option in cancer treatment

    Cristóbal Belda Iniesta, Olga Pernía, Rafael Simó Canonge

    • Resumen

    págs. 363-367

    

  • PET-CT in the staging and treatment of non-small-cell lung cancer

    Patricia Ibeas, B. Cantos Sánchez de Ibargüen, José Manuel Gasent, Begoña Rodríguez, Mariano Provencio Pulla

    • Resumen

    págs. 368-377

    

  • Current opinion in cervix carcinoma

    Silvia Rodríguez Villalba, Carmen Díaz-Caneja Planell, José Manuel Cervera Grau

    • Resumen

    págs. 378-384

    

  • The White Book of Radiation Oncology in Spain

    Ismael Herruzo Cabrera, Jesús Romero, Amalia Palacios Eito, Ana Mañas Rueda, Pilar Samper Ots, Eloísa Bayo Lozano, Ferrán Guedea Edo

    • Resumen

    págs. 385-395

    

  • The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.

    María José Safont, Mireia Gil Raga, Rafael Sirera Pérez, Eloisa Jantus Lewintre, Elena Sanmartín, Sandra Gallach, Cristina Caballero Díaz, Nieves del Pozo Alonso, Eugenio Palomares, Carlos Camps Herrero

    • Resumen

    págs. 396-400

    

  • The EORTC information questionnaire, EORTC QLQ-INFO25.: Validation study for Spanish patients

    Juan Ignacio Arrarás Urdániz, Ana Manterola Burgaleta, Berta Hernández Fierro, Fernando Arias de la Vega, Maite Martínez Aguillo, Meritxell Vila Viñas, Clara Eíto Valdovinos, Ruth Vera García, Miguel Angel Domínguez Domínguez

    • Resumen

    págs. 401-410

    

  • Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

    Vega Iranzo González-Cruz, Rafael Sirera Pérez, Alfredo Carrato Mena, Andrea Cabrera, Eloisa Jantus Lewintre, Ricardo Guijarro Jorge, Elena Sanmartín, Ana Blasco Cordellat, Mireia Gil Raga, José Lorenzo Gómez-Aldaraví Gutiérrez, José Luis González Larriba, Bartomeu Massuti Sureda, Amalia Velasco, Mariano Provencio Pulla, Rafael Rosell Costa, Carlos Camps Herrero

    • Resumen

    págs. 411-418

    

  • Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients

    Toshiaki Watanabe, Takashi Kobunai, Yoko Yamamoto, Keiji Matsuda, Soichiro Ishihara, Keijiro Nozawa, Hisae Iinuma, Tsuyoshi Konishi, Hisanaga Horie, Hiroki Ikeuchi, Kiyoshi Eshima, Tetsuichiro Muto

    • Resumen

    págs. 419-425

    

  • Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status

    Alfonso Sánchez Muñoz, Elisabeth Pérez Ruiz, María Isabel Sáez Medina, José Manuel Trigo Pérez, M. Mar Galindo, Lourdes Manzaneque, Begoña Jiménez, Begoña Muros, Emilio Alba

    • Resumen

    págs. 426-429